Get started
Author

Christianah Mojisola Adeyeye

Observed names: C. M. Adeyeye, Christiana Mojisola Adeyeye, Christianah Adeyeye, Mojisola C. Adeyeye, Mojisola Christianah Adeyeye
OpenAlex ID: A5067119620
Impact of ISO/IEC 17025 laboratory accreditation in sub-Saharan Africa: a case study
2020 · Mercy A. Okezue, Mojisola C. Adeyeye, et al. · BMC Health Services Research · 29
PDF
A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016
2019 · Comfort Kunak Ogar, Abiodun Abiola, et al. · Pharmaceutical Medicine · 18
Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria
2018 · Olufunsho Awodele, Rebecca Aliu, et al. · Pharmacology Research & Perspectives · 15
PDF
Integrating pharmaceutical systems strengthening in the current global health scenario: three ‘uncomfortable truths’
2020 · Tamara Hafner, Marlon Banda, et al. · Journal of Pharmaceutical Policy and Practice · 13
PDF
Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials—Is Africa the Answer? Report From a Satellite Session of the Accelerating Anti-Cancer Agent Development and Validation Workshop
2022 · Darya Kizub, Cathyryne K. Manner, et al. · JCO Global Oncology · 10
PDF
Cohort Event Monitoring for Safety Signal Detection in Adult Individuals 18 Years and Above after Immunisation with Coronavirus Disease 2019 Vaccines in Nigeria
2023 · Akinsanya O. Osibogun, Faisal Mohammed Shuaib, et al. · Nigerian Postgraduate Medical Journal · 5
Comparison of good review practices of seven countries participating in the ECOWAS medicines regulatory harmonisation initiative: identifying opportunities for improvement
2025 · Mercy Owusu-Asante, Delese Mimi Darko, et al. · Frontiers in Medicine · 4
PDF
Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in Nigeria
2024 · Uchenna Geraldine Elemuwa, Fraden Bitrus, et al. · Pharmaceutical Medicine · 3
Regulatory Performance of African National Medicines Regulatory Authorities Achieving WHO Maturity Level 3: Identifying Best Practices
2025 · Mercy Owusu-Asante, Delese Mimi Darko, et al. · Therapeutic Innovation & Regulatory Science · 2
PDF
Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial
2025 · Abideen Salako, Adesola Musa, et al. · Scientific Reports · 2
PDF
Secondary Validation of a Liquid Scintillation Counter-method for Residues of Tetracyclines, Beta-lactams, and Sulfonamides in Seafood/Aquaculture Products
2023 · Ololade Olabukola Aderibigbe, Bashar Bachaka Adamu, et al. · Journal of Food Protection · 2
Web-based Dossier Management System (DMS) and Emerging Technologies to Facilitate Faster Registration and Access to Human Drugs: NAFDAC’s Experience
2026 · Mojisola Christianah Adeyeye, Uche Sonny-Afoekelu, et al. · Therapeutic Innovation & Regulatory Science
Correction: Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial
2025 · Abideen Salako, Adesola Musa, et al. · Scientific Reports
PDF
The safety, quality evaluation, and lot release of COVID-19 vaccines imported and used in Nigeria from march 2021 to march 2022
2024 · N. M. Kanu, C. M. Adeyeye, et al. · Discover Health Systems
PDF
Trends of Covid-19 Vaccine Adverse Event Following Immunization (aefi): a One-year Retrospective Review Using the Passive Surveillance Data in the Nigerian National Database (vigiflow).
2024 · Uchenna Geraldine Elemuwa, Fraden Bitrus, et al.
Trends in Adverse Event Reporting Before and After the Introduction of the Medsafety App in Nigeria
2023 · Uchenna Geraldine Elemuwa, Fraden Bitrus, et al. · Zenodo (CERN European Organization for Nuclear Research)
Works count: 16
Citation count: 103
H-index: 5
I10-index: 5
Year
Topic
Type